Arcturus Therapeutics Ltd. announced that the Company has appointed Andrew Sassine as Chief Financial Officer (CFO), effective January 1, 2019. Mr. Sassine has been serving as Arcturus Interim Chief Financial Officer since August 2018 and has served on the Company's Board of Directors since May 2018. In addition to serving on the Arcturus board, Mr. Sassine serves on the boards of iCAD Inc. and Gemphire Therapeutics. Previously, Mr. Sassine served in various positions at Fidelity Investments from 1999 to 2012, most recently as portfolio manager.